Wockhardt Limited, a technology-driven global pharmaceutical and biotechnology major and its subsidiaries, has announced the signing of agreements to divest its Nutritional businesses to Abbott, the global health care company.

The company informed in a communiqué that company's wholly-owned subsidiary Carol Info Services Ltd has signed an agreement with Abbott to divest its nutrition contract manufacturing business along with its plant located in Lalru, Punjab in India.

It should be noted that Wockhardt has a significant presence in India's pediatric nutritional category with Farexr, Dexolacr and Nusobeer infant formulas and Farexr weaning cereal.

However, the transactions are subject to customary closing conditions and various approvals. The company expects the transactions to close in the second half of 2009.

Last month, Wockhardt Limited has signed an agreement to divest its Animal Health Division to Vétoquinol, France.